Research Topic

SIRT family in Endocrinology

About this Research Topic

Silent information regulator 1 (SIRT), also known as NAD-dependent deacetylase sirtuin, is a member of the class III group of histone deacetylases, collectively called sirtuins. The mammalian sirtuin family consists of 7 members, designated SIRT1 through SIRT7, which are characterized by a conserved 275-amino-acid catalytic core and unique additional N-terminal and C-terminal sequences of variable length. Previous studies have shown that SIRT can deacetylate many transcription factors, including forkhead box O (FOXO) transcription factors, p53, nuclear factor-κB (NF-κB), liver X receptor (LXR), and nuclear co-activators, as well, including peroxisome proliferator-activated receptor γcoactivator-1α(PGC-1α), cAMP-responsive element-binding protein–regulated transcription co-activator 2, and period homolog 2. It has been reported that SIRT family perform a wide variety of functions in a variety of biological systems, including obesity-associated metabolic diseases, endocrine disease, cancer, aging, cellular senescence, and oxidative stress, prion-mediated neurodegeneration, inflammation, and placental cell survival. Moreover, recent studies have demonstrated that SIRT play a pivotal roles in bone metabolism, cardiovascular diseases, diabetes, cancer, and neurological diseases.

We would like to collect potential articles involving Diabetes and Obesity, Cardiovascular endocrinology, Cellular endocrinology, Experimental Endocrinology, Molecular and Structural Endocrinology, Neuroendocrinology, Pediatric Endocrinology, Thyroid Endocrinology, et al. The main types of submitted manuscripts shall be Original Articles and Reviews. However, mini-review, meta-analysis, commentaries and other types are also welcomed.

This Research Topic will solicit original research articles, reviews, systematic review and meta-analysis, commentaries, etc that cover the themes of diabetes, thyroid diseases, cardiovascular metabolism, cancer endocrinology, bone metabolism.


Keywords: Diabetes, Cardiovascular medicine, Silent information regulator, Metabolism, Endocrinology


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Silent information regulator 1 (SIRT), also known as NAD-dependent deacetylase sirtuin, is a member of the class III group of histone deacetylases, collectively called sirtuins. The mammalian sirtuin family consists of 7 members, designated SIRT1 through SIRT7, which are characterized by a conserved 275-amino-acid catalytic core and unique additional N-terminal and C-terminal sequences of variable length. Previous studies have shown that SIRT can deacetylate many transcription factors, including forkhead box O (FOXO) transcription factors, p53, nuclear factor-κB (NF-κB), liver X receptor (LXR), and nuclear co-activators, as well, including peroxisome proliferator-activated receptor γcoactivator-1α(PGC-1α), cAMP-responsive element-binding protein–regulated transcription co-activator 2, and period homolog 2. It has been reported that SIRT family perform a wide variety of functions in a variety of biological systems, including obesity-associated metabolic diseases, endocrine disease, cancer, aging, cellular senescence, and oxidative stress, prion-mediated neurodegeneration, inflammation, and placental cell survival. Moreover, recent studies have demonstrated that SIRT play a pivotal roles in bone metabolism, cardiovascular diseases, diabetes, cancer, and neurological diseases.

We would like to collect potential articles involving Diabetes and Obesity, Cardiovascular endocrinology, Cellular endocrinology, Experimental Endocrinology, Molecular and Structural Endocrinology, Neuroendocrinology, Pediatric Endocrinology, Thyroid Endocrinology, et al. The main types of submitted manuscripts shall be Original Articles and Reviews. However, mini-review, meta-analysis, commentaries and other types are also welcomed.

This Research Topic will solicit original research articles, reviews, systematic review and meta-analysis, commentaries, etc that cover the themes of diabetes, thyroid diseases, cardiovascular metabolism, cancer endocrinology, bone metabolism.


Keywords: Diabetes, Cardiovascular medicine, Silent information regulator, Metabolism, Endocrinology


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

28 February 2018 Abstract
31 July 2018 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

28 February 2018 Abstract
31 July 2018 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..

Comments

Loading..

Add a comment

Add comment
Back to top